Targeting inhibition of GluR1 Ser845 phosphorylation with an RNA aptamer that blocks AMPA receptor trafficking

Journal of Neurochemistry

Volumn 108, Issue 1, 2009, Pages 147-157

  Liu, Yingmiao ^a   Sun, Qi An ^a   Chen, Qiang ^a   Lee, Tong H ^a   Huang, Yangzhong ^a   Wetsel, William C ^a   Michelotti, Gregory A ^a   Sullenger, Bruce A ^a   Zhang, Xiuwu ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aptamer; Glutamate receptor subunit 1; Phosphorylation; Protein kinase A; Protein kinase C; Trafficking

Indexed keywords

AMINO ACID; AMPA RECEPTOR; APTAMER; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUTAMATE RECEPTOR 1; GLUTATHIONE TRANSFERASE; GREEN FLUORESCENT PROTEIN; PROTEIN KINASE C; RECEPTOR SUBUNIT; RNA; SERINE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; HUMAN; HUMAN CELL; NERVE CELL; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN SECONDARY STRUCTURE; PROTEIN TARGETING; RAT; SYNAPSE;

AMINO ACID SEQUENCE; ANIMALS; APTAMERS, NUCLEOTIDE; BIOTINYLATION; CELLS, CULTURED; CEREBRAL CORTEX; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; GREEN FLUORESCENT PROTEINS; HUMANS; NEURONS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASE C; PROTEIN TRANSPORT; RATS; RECEPTORS, AMPA; SERINE; TRANSFECTION;

ESCHERICHIA COLI; MAMMALIA; RATTUS;

EID: 57249086446     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05748.x     Document Type: Article

References (54)

1. Bain J., McLauchlan H., Elliott M. Cohen P. (2003) The specificities of protein kinase inhibitors: an update. Biochem. J. 371, 199 204.
2. Banke T. G., Bowie D., Lee H., Huganir R. L., Schousboe A. Traynelis S. F. (2000) Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase. J. Neurosci. 20, 89 102.
3. Barry M. F. Ziff E. B. (2002) Receptor trafficking and the plasticity of excitatory synapses. Curr. Opin. Neurobiol. 12, 279 286.
4. Boudreau A. C. Wolf M. E. (2005) Behavioral sensitization to cocaine is associated with increased AMPA receptor surface expression in the nucleus accumbens. J. Neurosci. 25, 9144 9151.
5. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248 254.
6. Burgstaller P., Jenne A. Blind M. (2002) Aptamers and aptazymes: accelerating small molecule drug discovery. Curr. Opin. Drug Discov. Dev. 5, 690 700.
7. Carvalho A. L., Duarte C. B. Carvalho A. P. (2000) Regulation of AMPA receptors by phosphorylation. Neurochem. Res. 25, 1245 1255.
8. Cohen P. (2002a) The origins of protein phosphorylation Nat. Cell Biol. 4, 127 130.
9. Cohen P. (2002b) Protein kinases - the major drug targets of the twenty-first century? Nat. Rev. Drug Discov. 1, 309 315.
10. Cole A. L., Subbanagounder G., Mukhopadhyay S., Berliner J. A. Vora D. K. (2003) Oxidized phospholipid-induced endothelial cell/monocyte interaction is mediated by a cAMP-dependent R-Ras/PI3-kinase pathway. Arterioscler. Thromb. Vasc. Biol. 23, 1384 1390.
11. Crawford M., Woodman R. Ferrigno P. K. (2003) Peptide aptamers: tolls for biology and drug discovery. Brief. Funct. Genomic. Proteomic. 2, 72 79.
12. 2+/calmodulin- kinase II enhances channel conductance of alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionate type glutamate receptors. Proc. Natl Acad. Sci. USA 96, 3269 3274.
13. Durand G. Seta N. (2000) Protein glycosylation and diseases: blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring. Clin. Chem. 46, 795 805.
14. Edwards S., Graham D. L., Bachtell R. K. Self D. W. (2007) Region-specific tolerance to cocaine-regulated cAMP-dependent protein phosphorylation following chronic self-administration. Eur. J. Neurosci. 25, 2201 2213.
15. Ehlers M. D. (2000) Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting. Neuron 28, 511 525.
16. Ellington A. D. Szostak J. W. (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818 822.
17. Ellington A. D. Szostak J. W. (1992) Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures. Nature 355, 850 852.
18. Esteban J. A., Shi S. H., Wilson C., Nuriya M., Huganir R. L. Malinow R. (2003) PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity. Nat. Neurosci. 6, 136 143.
19. Farokhzad O. C., Karp J. M. Langer R. (2006) Nanoparticle-aptamer bioconjugates for cancer targeting. Expert Opin. Drug Deliv. 3, 311 324.
20. Gao C., Sun X. Wolf M. E. (2006) Activation of D1 dopamine receptors increases surface expression of AMPA receptors and facilitates their synaptic incorporation in cultured hippocampal neurons. J. Neurochem. 98, 1664 1677.
21. Griffin L. C., Toole J. J. Leung L. L. (1993) The discovery and characterization of a novel nucleotide-based thrombin inhibitor. Gene 137, 25 31.
22. Guo P. (2005) RNA nanotechnology: engineering, assembly and applications in detection, gene delivery and therapy. J. Nanosci. Nanotechnol. 5, 1964 1982.
23. Havekes R., Timmer M. Van der Zee E. A. (2007) Regional differences in hippocampal PKA immunoreactivity after training and reversal training in a spatial Y-maze task. Hippocampus 17, 338 348.
24. Hermann T. Patel D. J. (2000) Adaptive recognition by nucleic acid aptamers. Science 287, 820 825.
25. Hirao I., Harada Y., Nojima T., Osawa Y., Masaki H. Yokoyama S. (2004) In vitro selection of RNA aptamers that bind to colicin E3 and structurally resemble the decoding site of 16S ribosomal RNA. Biochemistry 43, 3214 3221.
26. Hunter T. (1994) 1001 Protein kinases redux towards 2000. Semin. Cell Biol. 5, 367 376.
27. Hunter T. (2000) Signaling - 2000 and beyond. Cell 100, 113 127.
28. Ishizaki J., Nevins J. R. Sullenger B. A. (1996) Inhibition of cell proliferation by an RNA ligand that selectively blocks E2F function. Nat. Med. 2, 1386 1389.
29. Lee H. K., Barbarosie M., Kameyama K., Bear M. F. Huganir R. L. (2000) Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity. Nature 405, 955 959.
30. Lewis D. L. Wolff J. A. (2007) Systemic siRNA delivery via hydrodynamic intravascular injection. Adv. Drug Deliv. Rev. 59, 115 123.
31. Lochner A. Moolman J. A. (2006) The many faces of H89: a review. Cardiovasc. Drug Rev. 24, 261 274.
32. Man H. Y., Sekine-Aizawa Y. Huganir R. L. (2007) Regulation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor trafficking through PKA phosphorylation of the Glu receptor 1 subunit. Proc. Natl Acad. Sci. USA 104, 3579 3584.
33. McNamara J. O. II., Andrechek E. R., Wang Y., Viles K. D., Rempel R. E., Gilboa E., Sullenger B. A. Giangrande P. H. (2006) Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat. Biotechnol. 24, 1005 1015.
34. Mi J., Zhang X., Rabbani Z. N., Liu Y., Su Z., Vujaskovic Z., Kontos C. D., Sullenger B. A. Clary B. M. (2006) H1 RNA polymerase III promoter-driven expression of an RNA aptamer leads to high-level inhibition of intracellular protein activity. Nucleic Acids Res. 34, 3577 3584.
35. Mi J., Zhang X., Rabbani Z. N. et al. (2008) RNA aptamer-targeted inhibition of NF-kappa B suppresses non-small cell lung cancer resistance to doxorubicin. Mol. Ther. 16, 66 73.
36. Murphy M. B., Fuller S. T., Richardson P. M. Doyle S. A. (2003) An improved method for the in vitro evolution of aptamers and applications in protein detection and purification. Nucleic Acids Res. 31, 110.
37. Perkins A. C. Missailidis S. (2007) Radiolabelled aptamers for tumour imaging and therapy. Q. J. Nucl. Med. Mol. Imaging 51, 292 296.
38. Rentmeister A., Bill A., Wahle T., Walter J. Famulok M. (2006) RNA aptamers selectively modulate protein recruitment to the cytoplasmic domain of beta-secretase BACE1 in vitro. RNA 12, 1650 1660.
39. Rusconi C. P., Scardino E., Layzer J., Pitoc G. A., Ortel T. L., Monroe D. Sullenger B. A. (2002) RNA aptamers as reversible antagonists of coagulation factor IXa. Nature 419, 90 94.
40. Sekine-Aizawa Y. Huganir R. L. (2004) Imaging of receptor trafficking by using alpha-bungarotoxin-binding-site-tagged receptors. Proc. Natl Acad. Sci. USA 101, 17114 17119.
41. Shen K., Hines A. C., Schwarzer D., Pickin K. A. Cole P. A. (2005) Protein kinase structure and function analysis with chemical tools. Biochim. Biophys. Acta 1754, 65 78.
42. Shi S. H., Hayashi Y., Petralia R. S., Zaman S. H., Wenthold R. J., Svoboda K. Malinow R. (1999) Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation. Science 284, 1811 1816.
43. Shiba K. (2006) Functionalization of carbon nanomaterials by evolutionary molecular engineering: potential application in drug delivery systems. J. Drug Target. 14, 512 518.
44. Snyder G. L., Allen P. B., Fienberg A. A., Valle C. G., Huganir R. L., Nairn A. C. Greengard P. (2000) Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo. J. Neurosci. 20, 4480 8448.
45. Sousa R. Padilla R. (1995) A mutant T7 RNA polymerase as a DNA polymerase. EMBO J. 14, 4609 4621.
46. Sullenger B. A., Gallardo H. F., Ungers G. E. Gilboa E. (1990) Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 63, 601 608.
47. Sun X., Zhao Y. Wolf M. E. (2005) Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons. J. Neurosci. 25, 7342 7351.
48. Suzuki T., Li W., Zhang J. P., Tian Q. B., Sakagami H., Usuda N., Kondo H., Fujii T. Endo S. (2005) A novel scaffold protein, TANC, possibly a rat homolog of Drosophila rolling pebbles (rols), forms a multiprotein complex with various postsynaptic density proteins. Eur. J. Neurosci. 21, 339 350.
49. Templin M. F., Stoll D., Schrenk M., Traub P. C., Vohringer C. F. Joos T. O. (2002) Protein microarray technology. Drug Discov. Today 7, 815 822.
50. Toulme J. J., Darfeuille F., Kolb G., Chabas S. Staedel C. (2003) Modulating viral gene expression by aptamers to RNA structures. Biol. Cell 95, 229 238.
51. Tropea T. F., Kosofsky B. E. Rajadhyaksha A. M. (2008) Enhanced CREB and DARPP-32 phosphorylation in the nucleus accumbens and CREB, ERK and GluR1 phosphorylation in the dorsal hippocampus is associated with cocaine conditioned place preference behavior. J. Neurochem. 106, 1780 1790.
52. Wong I. Lohman T. M. (1993) A double-filter method for nitrocellulose-filter binding: application to protein-nucleic acid interactions. Proc. Natl Acad. Sci. USA 90, 5428 5432.
53. Yano J., Hirabayashi K., Nakagawa S. et al. (2004) Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer. Clin Cancer Res. 10, 7721 7726.
54. Zhang X., Lee T. H., Davidson C., Lazarus C., Wetsel W. C. Ellinwood E. H. (2007) Reversal of cocaine-induced behavioral sensitization and associated phosphorylation of NR2B and GluR1 subunits of NMDA and AMPA receptors. Neuropsychopharmacology 32, 377 387.